Results 31 to 40 of about 284 (126)

Hypertension: Current trends and future perspectives

open access: yesBritish Journal of Clinical Pharmacology, Volume 87, Issue 10, Page 3721-3736, October 2021., 2021
Hypertension is a significant and increasing global health issue. It is a leading cause of cardiovascular disease and premature death worldwide due to its effects on end organs, and through its associations with chronic kidney disease, diabetes mellitus and obesity.
Paul G. Hunter   +2 more
wiley   +1 more source

Hope for resistant hypertension through BrigHTN and PRECISION

open access: yes, 2023
An estimated 10–15% of individuals with hypertension are resistant to available antihypertensive therapies. Findings from two new clinical trials — BrigHTN and PRECISION — that assessed the blood pressure-lowering effects of the aldosterone synthase ...
Touyz, R. M., Harrison, D. G.
core   +1 more source

New trials in resistant hypertension: mixed blessing stories. [PDF]

open access: yesClin Kidney J, 2023
Resistant hypertension (RH) is linked to an increased risk of cardiovascular and renal complications. Treatment options include non-pharmacological interventions, such as lifestyle modifications, and the use of specific antihypertensive drug combinations,
Zoccali C   +3 more
europepmc   +2 more sources

The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander   +206 more
wiley   +1 more source

Issue Information

open access: yes, 2023
The Journal of Clinical Hypertension, Volume 25, Issue 7, Page 583-586, July 2023.
wiley   +1 more source

Advancing antihypertensive drug development

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu   +5 more
wiley   +1 more source

The Cells of the Vasculature: Advances in the Regulation of Vascular Tone in the Brain and Periphery

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 136, Issue 5, May 2025.
ABSTRACT The vasculature is a complex tissue in which multiple cell types coordinate the regulation of tissue perfusion in response to hemodynamic and biochemical signals. Advances in this field are continuing to deepen our understanding of the relative importance of these cell types through the body.
Luke S. Dunaway   +3 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 7, Page 1416-1445, April 2025.
Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis   +16 more
wiley   +1 more source

Issue Information

open access: yes, 2022
The Journal of Clinical Hypertension, Volume 24, Issue 7, Page 791-794, July 2022.
wiley   +1 more source

Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension

open access: yesThe Journal of Clinical Hypertension, Volume 27, Issue 1, January 2025.
Abstract Resistant hypertension (RH) may cause severe target organ damage and poses significant challenges in the field of hypertension prevention and treatment. Mining biological characteristics is crucial for exploring the pathogenesis of RH and for early diagnosis and treatment.
Shanshan Wang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy